Peer-reviewedPublisher termsEuropean Journal of Medicinal Chemistry
Fragment-based drug discovery strategy reveals an unprecedented allosteric binding site in Mycobacterium tuberculosis DNA gyrase
Related
- X-ray crystallographic fragment screening reveals novel and conformationally dynamic ligand-binding sites in Mycobacterium tuberculosis FtsZ
- ESX-5 paralog deletions in Mycobacterium tuberculosis alter macrophage cytokine signaling and bacterial heavy metal response
- Switching from orthosteric to allosteric inhibition: Discovery of N-aryl-1H-azaindole-derived allosteric
- Mycobacterium tuberculosis gene expression dynamics in host environments with single-cell resolution
- Advancing Tuberculosis Antigen Detection by Selecting Sandwich-Compatible Aptamers Against the Mycobacterium tuberculosis ESAT-6/CFP-10 Heterodimer Using Library-Immobilized Strategies.
BibTeX
@article{shiroma2026fragmentbased,
title = {{Fragment-based drug discovery strategy reveals an unprecedented allosteric binding site in Mycobacterium tuberculosis DNA gyrase}},
author = {Sabrina Tami Shiroma and Nicolas de Oliveira Rossini and Jillian F Armenia and Catharina dos Santos Silva and Paulo C.T. Souza and Pierre-Damien Coureux and Neil Osheroff and Marcio V.B. Dias},
journal = {European Journal of Medicinal Chemistry},
year = {2026},
month = sep,
doi = {10.1016/j.ejmech.2026.119380},
url = {https://hal.science/hal-05787654v1},
}
RIS
TY - JOUR
TI - Fragment-based drug discovery strategy reveals an unprecedented allosteric binding site in Mycobacterium tuberculosis DNA gyrase
AU - Sabrina Tami Shiroma
AU - Nicolas de Oliveira Rossini
AU - Jillian F Armenia
AU - Catharina dos Santos Silva
AU - Paulo C.T. Souza
AU - Pierre-Damien Coureux
AU - Neil Osheroff
AU - Marcio V.B. Dias
PY - 2026
DA - 2026/09/29
JO - European Journal of Medicinal Chemistry
DO - 10.1016/j.ejmech.2026.119380
UR - https://hal.science/hal-05787654v1
SN - 0223-5234
SN - 1768-3254
ER -